• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾的肿块样多发性硬化症。

Tumefactive multiple sclerosis in Taiwan.

机构信息

Department of Neurology, Shuang-Ho Hospital, Taipei Medical University, Taipei, Taiwan.

出版信息

PLoS One. 2013 Jul 18;8(7):e69919. doi: 10.1371/journal.pone.0069919. Print 2013.

DOI:10.1371/journal.pone.0069919
PMID:23875010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3715463/
Abstract

BACKGROUND

Multiple sclerosis (MS) is less common in Asia, including Taiwan, and some characteristics of MS in Asians differ from those of Caucasians. Tumefactive brain lesion is even rarer in MS patients.

OBJECTIVE

To review patients with tumefactive MS and compare them with those in other studies investigating tumefactive demyelinating lesions and our Taiwanese typical MS patients.

METHODS

Twelve patients (6.3%) from the 190 MS patients visiting Taipei Veterans General Hospital from 1985 to 2010 were enrolled. They all fulfilled the McDonald or Poser criteria for MS and had at least one brain lesion larger than 2 centimeters with or without a mass effect.

RESULTS

Eleven patients (91.7%) were female and presented tumefactive brain lesions during the first attack. The clinical course of all patients was relapsing-remitting with a second attack within 2 years. Their initial extended disability status score was higher, but the prognosis was better after more than 2 years of follow-up, than in other studies. Moreover, our patients did not have optic or spinal involvement as well as positive neuromyelitis optica immunoglobulin or aquaporin-4 antibody, which is very common in Taiwanese MS patients.

CONCLUSION

Tumefactive MS is not common in Taiwan. Although the tumefactive demyelinating lesions seem to be terrible initially, their prognosis is relatively more favorable than expected.

摘要

背景

多发性硬化症(MS)在亚洲(包括中国台湾)较为少见,亚洲人的 MS 特征与白种人不同。在 MS 患者中,肿块样病变更为罕见。

目的

回顾性分析肿块样 MS 患者,并与其他研究中的肿块样脱髓鞘病变患者及我们台湾地区典型 MS 患者进行比较。

方法

纳入 1985 年至 2010 年间,在台北荣民总医院就诊的 190 例 MS 患者中的 12 例(6.3%)。所有患者均符合 McDonald 或 Poser 诊断标准,且至少有一处大于 2cm 的脑病变,伴或不伴有占位效应。

结果

11 例(91.7%)为女性,在首发时即表现为肿块样脑病变。所有患者的临床病程为复发缓解型,2 年内均有二次发作。与其他研究相比,这些患者的初始扩展残疾状况评分较高,但在 2 年以上的随访后,预后更好。此外,我们的患者没有视神经或脊髓受累,以及阳性视神经脊髓炎免疫球蛋白或水通道蛋白 4 抗体,这在台湾 MS 患者中非常常见。

结论

肿块样 MS 在台湾并不常见。虽然肿块样脱髓鞘病变在初始时看似严重,但预后比预期更为有利。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d456/3715463/64f38de1dacc/pone.0069919.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d456/3715463/062132efdf51/pone.0069919.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d456/3715463/be73fdfa05a3/pone.0069919.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d456/3715463/64f38de1dacc/pone.0069919.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d456/3715463/062132efdf51/pone.0069919.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d456/3715463/be73fdfa05a3/pone.0069919.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d456/3715463/64f38de1dacc/pone.0069919.g003.jpg

相似文献

1
Tumefactive multiple sclerosis in Taiwan.台湾的肿块样多发性硬化症。
PLoS One. 2013 Jul 18;8(7):e69919. doi: 10.1371/journal.pone.0069919. Print 2013.
2
Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.瘤样脱髓鞘病变的临床和影像学特征:随访研究。
Mult Scler. 2012 Oct;18(10):1448-53. doi: 10.1177/1352458512438237. Epub 2012 Mar 14.
3
Tumefactive Demyelination in MOG Ab-Associated Disease, Multiple Sclerosis, and AQP-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder.MOG 抗体相关性疾病、多发性硬化症和 AQP-4-IgG 阳性视神经脊髓炎谱系疾病中的肿块样脱髓鞘病变。
Neurology. 2023 Mar 28;100(13):e1418-e1432. doi: 10.1212/WNL.0000000000206820. Epub 2023 Jan 23.
4
Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.多发性硬化及相关疾病中的肿胀性脱髓鞘病变
Curr Neurol Neurosci Rep. 2016 Mar;16(3):26. doi: 10.1007/s11910-016-0626-9.
5
[The correlation factor analysis for conversion of clinically isolated syndrome to multiple sclerosis and neuromyelitis optica].[临床孤立综合征向多发性硬化症和视神经脊髓炎转化的相关因素分析]
Zhonghua Nei Ke Za Zhi. 2016 Jun;55(6):460-5. doi: 10.3760/cma.j.issn.0578-1426.2016.06.012.
6
Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.脑和脊髓病变标准将 AQP4 阳性视神经脊髓炎和 MO G 阳性疾病与多发性硬化症区分开来。
Mult Scler Relat Disord. 2018 Oct;25:246-250. doi: 10.1016/j.msard.2018.08.008. Epub 2018 Aug 9.
7
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.病理确诊的肿胀型多发性硬化症的临床和影像学表现谱
Brain. 2008 Jul;131(Pt 7):1759-75. doi: 10.1093/brain/awn098. Epub 2008 Jun 5.
8
Spinal cord and brain corticospinal tract lesions are associated with motor progression in tumefactive multiple sclerosis.脊髓和脑皮质脊髓束病变与肿块型多发性硬化症的运动进展有关。
Mult Scler Relat Disord. 2023 May;73:104614. doi: 10.1016/j.msard.2023.104614. Epub 2023 Mar 12.
9
Characterisation of the spectrum of demyelinating disease in Western Australia.西澳大利亚脱髓鞘疾病谱系的特征描述。
J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1022-6. doi: 10.1136/jnnp.2007.131177. Epub 2008 Mar 20.
10
Interferon-β-related tumefactive brain lesion in a Caucasian patient with neuromyelitis optica and clinical stabilization with tocilizumab.一名患有视神经脊髓炎的白种患者出现与干扰素-β相关的瘤样脑病变,使用托珠单抗后临床症状稳定。
BMC Neurol. 2014 Dec 17;14:247. doi: 10.1186/s12883-014-0247-3.

引用本文的文献

1
Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions.经病理证实的非典型肿块样脱髓鞘病变的临床谱及预后。
Sci Rep. 2023 May 13;13(1):7773. doi: 10.1038/s41598-023-34420-4.
2
Tissue donations for multiple sclerosis research: current state and suggestions for improvement.用于多发性硬化症研究的组织捐赠:现状与改进建议。
Brain Commun. 2022 Apr 19;4(2):fcac094. doi: 10.1093/braincomms/fcac094. eCollection 2022.
3
A comparison of brain magnetic resonance imaging lesions in multiple sclerosis by race with reference to disability progression.

本文引用的文献

1
Evolution and long term outcome in patients presenting with large demyelinating lesions as their first clinical event.以大的脱髓鞘病变为首发临床事件的患者的演变和长期预后。
J Neurol Sci. 2010 Oct 15;297(1-2):29-35. doi: 10.1016/j.jns.2010.06.030. Epub 2010 Aug 1.
2
Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.肿瘤样脱髓鞘病变超过 30mm 的患者的特征性神经影像学表现。
J Neuroimaging. 2011 Apr;21(2):e69-77. doi: 10.1111/j.1552-6569.2010.00502.x.
3
Prevalence of multiple sclerosis in Canada: a systematic review.
种族与残疾进展相关的多发性硬化症脑磁共振成像病变的比较。
J Neuroinflammation. 2018 Sep 5;15(1):255. doi: 10.1186/s12974-018-1295-1.
4
MRI Findings in Tumefactive Demyelinating Lesions: A Systematic Review and Meta-Analysis.MRI 表现对肿块样脱髓鞘病变的诊断价值:系统评价和荟萃分析
AJNR Am J Neuroradiol. 2018 Sep;39(9):1643-1649. doi: 10.3174/ajnr.A5775. Epub 2018 Aug 16.
5
Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.经病理证实的肿块样脱髓鞘病变患者的临床与影像相关性。
J Neurol Sci. 2017 Oct 15;381:83-87. doi: 10.1016/j.jns.2017.08.015. Epub 2017 Aug 10.
6
Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System.《中国中枢神经系统肿瘤样脱髓鞘病变诊断与治疗指南》
Chin Med J (Engl). 2017 Aug 5;130(15):1838-1850. doi: 10.4103/0366-6999.211547.
7
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.多发性硬化症中肿胀性脱髓鞘病变的发生情况及长期预后
Neurol Sci. 2016 Jul;37(7):1113-7. doi: 10.1007/s10072-016-2558-1. Epub 2016 Apr 15.
8
Post-operative quadriplegia as the initial manifestation of tumefactive multiple sclerosis.术后四肢瘫痪作为肿胀型多发性硬化的初始表现
Indian J Crit Care Med. 2015 Jun;19(6):359-61. doi: 10.4103/0972-5229.158281.
9
Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.孤立性肿胀性脱髓鞘病变:一项多中心研究中16例患者的诊断及长期演变情况
J Neurol. 2015 Jul;262(7):1637-45. doi: 10.1007/s00415-015-7758-8. Epub 2015 May 1.
加拿大多发性硬化症的患病率:一项系统综述。
Can J Neurol Sci. 2008 Nov;35(5):593-601. doi: 10.1017/s0317167100009380.
4
Tumefactive demyelinating lesions: nine cases and a review of the literature.肿胀性脱髓鞘病变:9例病例及文献综述
Neurosurg Rev. 2009 Apr;32(2):171-9; discussion 179. doi: 10.1007/s10143-009-0185-5. Epub 2009 Jan 27.
5
Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.病理确诊的肿胀型多发性硬化症的临床和影像学表现谱
Brain. 2008 Jul;131(Pt 7):1759-75. doi: 10.1093/brain/awn098. Epub 2008 Jun 5.
6
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.日本多发性硬化症中水通道蛋白4自身免疫性和脊髓病变的异质性
Brain. 2007 May;130(Pt 5):1206-23. doi: 10.1093/brain/awm027. Epub 2007 Apr 17.
7
Clinical characteristics of multiple sclerosis in Taiwan: a cross-sectional study.台湾多发性硬化症的临床特征:一项横断面研究。
Mult Scler. 2006 Aug;12(4):501-6. doi: 10.1191/1352458506ms1297oa.
8
Multiple sclerosis: pseudotumoral forms.多发性硬化症:假瘤样形式。
Neurol Sci. 2004 Nov;25 Suppl 4:S374-9. doi: 10.1007/s10072-004-0345-x.
9
Multiple sclerosis in Taiwan.台湾的多发性硬化症。
J Chin Med Assoc. 2004 Oct;67(10):500-5.
10
Multiple sclerosis in the Japanese population.日本人群中的多发性硬化症。
Lancet Neurol. 2003 Feb;2(2):117-27. doi: 10.1016/s1474-4422(03)00308-9.